SCHEMBL9019771

SCHEMBL9019771

CC(C)OCC(COC(C)C)OCn1cnc2nc(N)nc(OC(C)C)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 7/20 0.40
CCNB1 P14635 7/20 0.40
CCNA2 P20248 7/20 0.40
CDK2 P24941 7/20 0.40
CCNA1 P78396 7/20 0.40
TLR7 Q9NYK1 2/20 0.32
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
ADORA2A P29274 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
NFKB1 P19838 1/20 0.30
BLM P54132 1/20 0.30
VCP P55072 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HIF1A Q16665 1/20 0.30
PDE3A Q14432 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9019801 0.91 TLR7 (0.36) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL9019783 0.88 ADORA2A (0.35) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL9019778 0.82 TLR7 (0.39) TLR7
SCHEMBL9019744 0.77 ALDH1A1 (0.32) MEN1ALDH1A1LMNACYP3A4NFKB1
SCHEMBL9019822 0.75 MEN1 (0.48) MEN1ALDH1A1LMNACYP3A4NFKB1
SCHEMBL9827507 0.73 PDE3A (0.44) CDK1CCNB1CDK2HSP90AA1HSP90AB1
SCHEMBL9019742 0.72 ACHE (0.33) MEN1ALDH1A1LMNACYP3A4NFKB1
SCHEMBL9019773 0.71 PDE3A (0.39) MEN1ALDH1A1LMNACYP3A4NFKB1
SCHEMBL9019784 0.70 ALDH1A1 (0.36) ALDH1A1
Rociclovir SCHEMBL1228859 0.69 ALDH1A1 (0.49) CDK1CCNB1CDK2HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed